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ABSTRACT
OBJECTIVE: The objective of this selective EBM review is to determine whether or not, “Is
laser therapy an effective alternative treatment for onychomycosis in patients where the
hepatotoxicity of oral antifungals is of concern?”
STUDY DESIGN: Review of three English language primary studies, published between 2010
and 2012.
DATA SOURCES: Two randomized controlled trials (RCTs) and one prospective cohort study
were found using Cochrane Systematic Reviews and PubMed. These studies analyzed the
effectiveness of laser therapy in patients with onychomycosis.
OUTCOMES MEASURED: Main outcomes measured were nail clearance and mycological
assessment. Nail clearance was determined clinically using photographs taken at different
intervals and mycological assessment was determined by microscopic exam. Adverse effects
were tracked in all studies and patient satisfaction was considered in one study. The tools used
to assess significance of outcomes measured were p-values, percentage of nail clearance, and
negative mycological assessment.
RESULTS: All three studies showed a significant nail clearance and fungal culture after laser
therapy intervention. In the Ladsman et al study, it was shown using an 870 and 930-nm laser
improved nail clearance by at least 3mm (p<0.0073) and negative fungal cultures in 42% of the
toes after one treatment and 75% on day 60 with an (ABI of 40%).1 In the Zhang et al study, the
Long-Pulse 1064-nm laser showed no significant difference in treatment duration, but did show
positive improvement in nail clearance and fungal cultures regardless the duration of treatment.2
In the Kimura et al prospective cohort study, it was shown using the Sub-Millisecond 1064-nm
laser showed complete clearance in 51% and significant clearance in 81% of patients. Of the
51% with complete clearance, they also were 100% negative on fungal culture.3
CONCLUSSION: The results of one RCT and one cohort study which compared before and
after treatment groups demonstrated that laser therapy may be an effective treatment for
onychomycosis in patients that may not be able to take oral antifungals for reasons medically
indicated. One RCT compared effectiveness of varied treatment durations and found no
significant difference between the two groups.
KEY WORDS: Onychomycosis, Tinea Unguium, Laser Therapy.
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INTRODUCTION
Onychomycosis (Tinea Unguium) is a trichophyton infection of one or more (but rarely
all) fingernails or toenails.4 The fungal infection most commonly causes brittleness, yellowish
discoloration, and hypertrophic changes causing a deformity in the nail.4 Rarely does it cause
pain. Most commonly, it is more a cosmetic concern; however, secondary infection is of concern
in diabetics and in the immunocompromised patient.4
The overall prevalence rate is 2% to 3%2; however, the prevalence rate increases to 14%
to 28% in persons over the age of 60.3 Onychomycosis is most often an incidental finding
during a routine physical exam and rarely the main reason for a patient visit to their healthcare
professional. Onychomycosis is the most common inflammatory disease of the nails,
representing 15-40% of all nail disturbances.6 It is most commonly caused by T. rubrum4 and T.
mentagrophytes.5 Other etiologies like yeasts and fungi are also common causes.5 Nails become
lusterless, brittle, hypertrophic, and the substance of the nail becomes friable.4
Total annual cost could not be determined; however, they estimated the cost of diagnosis,
drug acquisition, and management of adverse reactions per person using Griseofulvin,
itraconazole (continuous therapy), Itraconazole (pulse therapy), and fluconazole is $4917, $2072,
$1072, and $1042 respectively.5 Recently Laser therapy has been studied in the treatment of
onychomycosis and the estimated cost is $750 to $1,000 per person. Although less expensive,
insurance companies have not yet recognized laser therapy as an alternative treatment and do not
cover the cost.
From 1994 to 2004 in the USA, there were 51 million visits for superficial fungal
infections in which Onychomycosis represented 23.2% of all dermatophyte visits.6 This adds up
to approximately 1,219,820 visits per year or 433 per 100,000 doctor appointments.6
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Until recently, oral antifungals and/or surgical removal of the nail were the mainstay of
treatment. Although oral antifungals are found to be extremely effective, they do carry with
them a side effect profile of hepatotoxicity. As mentioned earlier, onychomycosis is seen more
commonly in the elderly; therefore, oral antifungals are rarely an option. Surgical removal is
invasive and carries the risk of secondary infection which limits the use in the diabetic and/or
immunocompromised population. Prior to a newly FDA approved topical antifungal, topicals
were rarely used due to their inability to penetrate the nail; therefore, were deemed ineffective in
the treatment of onychomycosis.
Although the treatment options mentioned above are effective, they are known to be
hepatotoxic, invasive, and carry a higher cost. There is a reported 10% to 53% recurrence or
relapse rate3 which therefore requires longer duration treatments making patient compliance a
concern, higher costs to insurers, and more importantly, the associated hepatotoxicity. Laser
therapy has shown some promise in the non-invasive and non-hepatotoxic treatment of
onychomycosis. Thus far, numerous studies have been conducted and results vary slightly on
type of laser and duration of treatment; however, regardless of the treatment, all studies are
showing positive nail clearance and negative fungal cultures post treatment. Also, the use of
laser therapy has no known side effects and if anything, slight warmth at treatment site might be
noted.
OBJECTIVE
The objective of this selective EBM review is to determine whether or not, “Is Laser
Therapy an effective alternative treatment for onychomycosis in patients where the
hepatotoxicity of oral antifungals is of concern?”
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METHODS
The population age range for the review ranged from 18 to 75 years of age with
diagnostic evidence of Onychomycosis. The studies involved the interventional use of the
Noveon Dual-wavelength near-infrared diode laser, Pinpointe Footlaser long-pulse Nd: YAG
1064-nm laser, and Sub-millisecond 1064-nm ND: YAG lasers. The comparison groups in the
two RCTs received either a Sham treatment, lower dose treatment, or a shorter duration of
treatment. In the Prospective Cohort study, no comparison group was utilized. The outcomes
were measured clinically and by mycological assessments. Photographs were taken at prescribed
intervals to determine nail clearance along with fungal cultures being tested post-protocol. The
three studies consisted of two Randomized Control Studies and one prospective cohort study.
A detailed search using Cochrane Systematic Reviews and PubMed databases were
completed by the author using the keywords “Onychomycosis,” “Tinea Unguium,” “Laser
Therapy.” Articles were selected based on their relevance to clinical practice and importance to
patient-oriented outcomes (POEMs-Patient Oriented Evidence that Matters). All articles chosen
for this review were peer-reviewed and published in well-known journals. Inclusion criteria
consisted of articles that were either RCTs or Primary studies published after 2000 in which no
other systematic review, meta-analysis, or review article was found on the COCHRANE
database answering the same question. Studies excluded were those with patients treated with
other treatment modalities such as oral antifungals, topical antifungals, or surgically removed
nails. A summary of statistics reported or used were RBI, ABI, NNT, and P-values. Table 1
displays the demographics and characteristics of these articles.
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Table 1 – Demographics and Characteristics of Included Studies
Study

Type

#
Pts
13

Age
(yrs)
37-88

Inclsusion Criteria

Exclusion Criteria

W/D

Interventions

Positive fungal
infection diagnosis
via KOH and
microscopic
examination.

If they were
prescribed oral
antifungals within 1
year of study, topical
antifungals within 1
week of study, had a
serious generalized
medical condition, or
the potential to be
pregnant.

0

Sub-millisecond
1,064-nm ND:
YAG Laser

Kimura³
(2012)

Prospective
Cohort
Study

Landsman¹
(2012)

SingleBlind RCT

34

18-70

At least one great
toe with distal,
lateral, or
superficial white
onychomycosis
that did not involve
the lunula or
extend to the
eponychium.
Positive laboratory
confirmation of
onychomycosis.
Fitzpatrick skin
color grading: 1-4.

Fitzpatrick Skin Color
Grading 5 & 6
(Darkest shades),
patients with a history
of psoriasis, lichen
planus, or a history of
trauma to toe
involved,
immunocompromised,
or patients who
received prescription
antifungal
medications within
the last 6 months.

0

Noveon DualWavelength nearinfrared Diode
Laser.

Zhang²
(2012)

SingleBlind RCT

33

18-75

Clinical Diagnosis
of onychomycosis.
Positive results of
fungal direct
microscopic
examination.
Positive fungal
culture with
Sabouraud's
medium.

If they were
prescribed topical
antifungals within 1
month, systemic
antifungals within 6
months, stopped or
altered treatment plan,
pregnancy,
hematoma, nevoid,
psoriasis, lichen
planus, atopic
dermatitis, or bacterial
infection.

0

Pinpointe
Footlaser longpulse ND: YAG
1064-nm laser.

OUTCOMES MEASURED
The outcomes measured were POEMs. Outcomes were measured in a variety of ways to
include Clinical assessment, photographic images, laboratory studies, patient satisfaction, and
safety. Landsman et al used three criteria in the evaluation of outcomes: nail clearance,
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mycological assessment, and safety. Photographs were taken on day 0, 14, 42, 120, and 180.
They graded the nail clearance as follows: completely cleared, markedly improved, slightly to
moderately improved, or unchanged. The photographs were reviewed by the investigators and
an independent panel to ensure integrity of the study. Fungal cultures utilizing acid-Schiff
staining were taken at baseline and periodically throughout the study and graded accordingly. In
determining nail clearance, outcomes were measured based on at least 3mm of clear linear
growth. Adverse effects noted during the trial were documented. Zhang et al used four
categories of outcome measurement: nail clearance, mycological effects, patient satisfaction,
and safety. Nail clearance in which nail samples were taken before treatment and at weeks 8, 16,
and 24 and were graded by percentage of nail clearance. Four categories were used: 1. Fullgrown new nail with < 5% defects. 2. Significant effect with >60% newly grown nail. 3.
Improvement with >20% and <60% newly grown nail. 4. Inefficacy with <20% newly grown
nail. During nail sampling, fungal cultures were also taken to determine mycological effect of
treatment. Subjective data was collected and used to determine patient satisfaction and were
graded as follows: not satisfied, generally satisfied, satisfied, and very satisfied. Any adverse
effects noted during the trial were documented. Kimura et al focused their study on two
assessments that were summed up into one score. The two assessments were based off level of
improvement in Turbidity score and mycological assessment. Assessment of turbidity was
conducted at baseline and 16 weeks post study. Utilizing photographs, the investigator and two
separate dermatologists analyzed the photographs. Mycological assessments were conducted
using a KOH prep. Combined assessments were given a score of 0 to 4 with 0 representing no
nail clearance and 4 representing complete nail clearance. Any adverse effects noted during the
trial were documented.
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RESULTS
The three studies chosen evaluated the effectiveness in laser therapy for the treatment of
onychomycosis and did not compare laser therapy to standard treatment practices. All subjects
included in each study were assessed prior to treatment and assessed throughout the study at
prescribed intervals. All of the studies utilized laser therapy as the intervention, but varied
slightly the type of laser utilized and duration of treatment. Each study had similar inclusion and
exclusion criteria (see Table 1). Throughout each of the studies, safety and protocols were
followed. Temperature of nail beds were monitored, settings on lasers were verified, and all
adverse events were documented.
The study conducted by Landsman et al consisted of 34 subjects randomly assigned to a
treatment group (n = 25) or a control group (n = 9). Also included in the randomization was
number of eligible toes: treatment group (n = 26) and the control group (n = 11). Prior to
treatment protocols and to ensure laser accuracy, the laser was calibrated before and after each
treatment. Each patient and/or toe received a total of four treatments: days 1, 14, 42, and 120.
Each treatment consisted of two does of laser therapy: first dose consisted of a 4-minute
exposure using both 870 and 930 nm simultaneously and the second dose consisted of a 2-minute
exposure with a 930 nm dose. The control group followed the exact protocols as that for the
treatment group, but instead received what they call a “sham treatment”. Sham treatment
consisted of the same laser, same treatment number, and same durations. All that differed was
the setting on the laser which was set at 0 (no energy output).1
A variety of outcomes were measured during this study, but for purposes of this review,
only two of the three outcomes were used: Nail clearance and Mycological assessment. As
mentioned in the outcomes measured section, photographs were used to assess nail clearance and
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acid-Schiff staining methods were used for mycological assessment. According to the study,
laser therapy was shown to be effective in achieving at least 3mm of nail clearance (p = 0073)
when compared to the control group. Also, there was a negative mycological assessment of 64%
at day 120 post treatment; however, was not compared to the control group. Combined, there
was a 39% that achieved negative fungal cultures and nail clearance of at least 3mm on day 180
of the study.1
Table 2 – Results of 870 and 930-nm Laser Therapy1

Nail Clearance of at least 3mm

RBI

ABI

NNT

P-value

5%

40%

3

0.0073

The study conducted by Zhang et al consisted of 33 subjects randomly assigned to group
1 (n = 15) and group 2 (n = 18). Also included in the randomization was number of eligible toes:
group 1 (n = 78) and group 2 (n = 76). Group 1 was to receive two courses of treatment (eight
sessions) whereas Group 2 was to receive a single course of treatment (4 sessions). There was
not a control group in their study. Groups were randomly selected and only varied in their
treatment durations. Intervention was accomplished by the use of the Pinpointe Footlaser longpulse Nd:YAG 1064-nm laser. A full course is defined as having four sessions on days 0, 7, 14,
and 21.2
A variety of outcomes were measured in this study to include fungal cultures and
microscopic examinations, clinical evaluations, patient satisfaction, and safety. Outcomes were
measured on days 8, 16, and 24. This study did not focus on whether or not laser therapy is
effective, but more the effectiveness of different treatment prescriptions. According to the study,
there was not a significant difference in clinical assessment between the two groups (p>0.05).
Patient satisfaction was an overall 87% with 4 subjects being unsatisfied. On mycological

Heath, Laser Therapy & Treatment of Onychomycosis 8

assessment, there appeared to be a high recurrence rate with positive cultures appearing higher at
week 24. No reported adverse event occurred in any of the 33 subjects. Table 3 summarizes the
results of the study by Zhang et al.2
Table 3 – Clinical Effectiveness and Positive Fungal Cultures2
Week 8
Clinical Effectiveness
Group 1
Group 2
Positive Mycological Assessment
Group 1
Group 2

Week 16

Week 24

63%
68%

62%
67%

51%
53%

13%
11%

20%
11%

27%
11%

The study conducted by Kimura et al was a Prospective Cohort study consisting of 13
subjects that demonstrated turbidity in 37 toenails along with positive microscopic analysis.
Intervention utilized in this study was the Sub-millisecond 1064-nm Nd:YAG laser. Treatments
consisted of 1 to 2 minutes per toenail with 4 to 8 weeks between sessions. The 13 subjects were
treated differently with seven subjects receiving three sessions, five subjects receiving two
sessions, and one subject receiving one session.3
Two outcomes were measured in this study and summed to provide the investigators with
one score. Clinical assessment of turbidity was achieved via photographs taken at baseline and
weeks 4, 8, 12, 16, 20, and 24. At week 24, if a subject presented for follow up with 100%
turbidity clearance, a microscopic analysis was then performed and the subject was graded
accordingly. Overall, 81% of subjects received moderate to complete clearance post treatment.
Of the 16% with no clearance, it was noted at baseline they had a turbidity score of 10 which
indicated a completely turbid nail. Other than a slight warmness sensation during treatment
sessions, no adverse effects were noted significant. Table 4 illustrates the results of overall
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improvement at final follow-up with complete clearance also indicating a negative microscopic
result.3
Table 4: Overall Improvement3
Complete Significant Moderate Slight
No
Clearance Clearance Clearance Clearance Clearance
51%
19%
11%
3%
16%

DISCUSSION
The results from these studies demonstrate that laser therapy is an effective and safe
alternative treatment for onychomycosis. Although none of the studies compared laser therapy
directly to already proven treatments, as far as effectiveness goes, these early studies show
promise. However, before insurance companies consider compensation for such treatments,
further studies should be conducted comparing the two.
Throughout the studies, there were limitations that may have altered the results.
According to the Landsman et al study, fungal cultures could result in false positives if not
enough new nail growth occurs prior to sample. They believe dead pathogens are still
recognized in the nail tissue; therefore, showing positive nail fungus.1 The Lang et al study
believes numerous factors could have contributed to the results. They feel the lack of
effectiveness could have been due to treatment duration, treatment depth, laser energy, and
different fungal strains having varied sensitivities to laser therapy. Treatment variations based
on cultured pathogen must be made to effectively kill fungi as today’s medicine does with
antibiotics.2 Also considered a contributing factor was the reoccurrence and relapse rates. Were
all subjects taking the same preventative measures? Is recurrent rate high regardless? Like
mentioned earlier, recurrence and relapse rates are high even in today’s mainstay of treatment.
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In doing the initial search, this researcher found there to be few RCTs or other peerreviewed studies conducted on the effectiveness of laser therapy. The studies reviewed met all
requirements of the IRB, followed strict protocols and were randomly selected; however, sample
sizes were small and no study compared laser therapy to standard therapies such as oral
antifungal use.
CONCLUSION
Laser therapy is an effective alternative treatment for onychomycosis. All three studies
showed evidence of effective clearance of nails and negative mycological assessments poststudy. Although not directly compared to current treatments, laser therapy has proven to be just
as effective if not more effective to the 59% mycological cure rate of oral antifungals.1 Also,
there were no concerning adverse effects noted in any of the studies.
Due to the limited amount of studies, small sample sizes, and no comparison studies,
future studies are needed to directly compare laser therapy with today’s standard treatments of
oral and topical antifungals as well as comparing the many different types of lasers currently
being used to treat onychomycosis. Thus far, results appear to be promising and the possibility
of having a cheaper, safer, and more effective treatment available to the consumer is in the near
future.
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